Australia Lipase Market Size, Share and Outlook: Forecast Trends and Growth Analysis Report (2026-2035)

Key Market Trends and Insights

• Microbes-derived options are expected to dominate this segment of the market.
• By form, powder formulations are projected to lead the market.
• Based on the function, the food and beverage texturants are likely to hold a significant market share.
• The bakery and confectionery segment is anticipated to have a substantial share during the forecast period.

Market Size and Forecast

• CAGR (2026-2035): 6.80% 
• Largest Market in 2025: New South Wales

Australia Lipase Market Overview

Lipase plays a vital role in various biological and industrial processes, particularly in the breakdown and processing of dietary fats. It is widely used across sectors such as food and beverages, pharmaceuticals, and biotechnology for its enzymatic efficiency and specificity. The market has experienced steady growth due to rising demand in food processing, dietary supplements, and pharmaceutical applications. Increased awareness of enzyme-based products and advancements in biotechnology further support market expansion. The market reflects a strong potential for continued development driven by innovation and health-focused consumer trends.

Australia Lipase Market Growth Driver

Rising Pancreatic Cancer Cases to Drive the Growth in the Market

The increasing prevalence of pancreatic cancer is a key factor contributing to the growth of the lipase market in Australia. According to the Cancer Council, pancreatic cancer is the 8th most diagnosed cancer in the country, with an estimated 1 in 70 Australians likely to be diagnosed by the age of 85. Growing awareness regarding early disease detection and the expanding use of enzyme-based diagnostics, including lipase, are supporting advancements in clinical testing. This rising need for efficient diagnostic tools is expected to significantly support the expansion of the market.

Australia Lipase Market Trends

Some of the trends in the market include the regulatory approval of genetically modified lipases and the growing support for RNA-based therapies.

Regulatory Approval of GM-Derived Lipases to Boost Market Demand

The market is witnessing advancements in food enzyme regulations. For instance, in February 2025, Food Standards Australia New Zealand (FSANZ) approved Application A1301, allowing the use of triacylglycerol lipase derived from genetically modified Komagataella phaffii as a processing aid in the production of bread and bakery products. Submitted by Danstar Ferment AG, an affiliate of Lallemand Inc., this approval marks a key milestone in expanding enzyme use. This development is anticipated to significantly enhance market growth.

Adoption of RNA-Based Therapies to Boost Australia Lipase Market Demand

The development of RNA-based therapies is supporting growth in the Australian market, particularly in clinical applications targeting lipid metabolism disorders. For instance, in September 2024, data presented at the European Society of Cardiology Congress showed that plozasiran, a small interfering RNA (siRNA) therapy, significantly reduced triglyceride levels and the risk of pancreatitis in patients with chylomicronemia. By silencing ApoC-III, a natural inhibitor of lipoprotein lipase, the therapy improved lipid clearance. This advancement underscores the growing role of RNA therapeutics in enhancing lipase activity, contributing to the market’s expansion in Australia.

Australia Lipase Market Share

Microbials are Expected to Lead Market by Source

Various sources, such as plants, animals, and microbes, contribute to the production of lipase enzymes in the market. Each source offers unique advantages for applications across food processing, pharmaceuticals, and industrial sectors. However, the microbial segment is expected to lead the market due to its higher enzyme yield, ease of fermentation, and cost-effective production. Additionally, microbial lipases exhibit excellent stability and specificity, making them highly suitable for large-scale industrial applications.

Australia Lipase Market Analysis by Region

The market is divided into regions such as New South Wales, Victoria, Queensland, Australian Capital Territory, Western Australia, and Others. Among these, New South Wales is expected to lead the market, driven by the growing prevalence of obesity and related metabolic disorders. According to the NSW Population Health Survey (May 2025), in 2024, 35% of adults aged 16 years and over were overweight, while another 27% were obese. Being overweight and obese were the leading risk factors contributing to Australia’s disease burden in 2024. This growing health concern is expected to drive increased demand for lipase-based solutions across the region.

Leading Players in the Australia Lipase Market

The Australia lipase market research report by Expert Market Research provides an in-depth analysis of the competitive landscape, offering key insights into funding trends, investments, and strategic initiatives by major players. It tracks recent investments, mergers, acquisitions, and partnerships that showcase the market's growth trajectory. Additionally, the report details strategic activities by leading companies, including regional expansions, adoption of new technologies, and efforts to enhance capacity, helping stakeholders better understand the market dynamics and positions of key industry players. Some of the leading players are as follows:

Kerry Group plc

Kerry Group plc, a global leader in enzyme innovation, is actively involved in the lipase market through its advanced biotechnology capabilities and enzyme application expertise. The company offers tailored enzyme solutions that enhance processing efficiency, improve product shelf life, and optimize nutritional value across sectors such as dairy, bakery, and dietary supplements. Kerry’s sustainable and science-driven approach addresses complex manufacturing challenges, supporting improved product performance and operational outcomes within the evolving lipase market.

Home Make-It Pty. Ltd

Home Make-It Pty. Ltd., a family-owned Australian company, is a specialist provider of food and beverage equipment and supplies, with years of local expertise. The company supports lipase-related applications through its extensive offerings in cheese, salami, and sausage making. These processes often rely on enzymatic activity, including lipase, for flavor and texture development, positioning Home Make-It as a supportive player in the market through equipment and culture supply.

Green Living Australia (QLD) Pty. Ltd

Green Living Australia (QLD) Pty. Ltd is a key player in the Australian lipase market, specializing in home-based cheese making and fermentation products. The company offers Lipase Powder – 20 grams in Sterile Jar, used to enhance the flavor of traditional cheeses like Romano and Parmesan by breaking down milk fats. Its involvement supports artisanal and home cheese production across Australia.

Key Questions Answered in the Australia Lipase Market Report

• What was the Australia lipase market value in 2025?
• What is the Australia lipase market forecast outlook for 2026-2035?
• What are the major factors aiding the Australia lipase market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Australia lipase market trends?
• Which source is expected to dominate the market segment?
• Which form is projected to lead the market segment?
• Which function is anticipated to drive the market segment?
• Which application is likely to dominate the market segment?
• Who are the key players involved in the Australia lipase market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?